Clinical Trial

Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 1, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to compare the changes in AQP -4, -5, -9, and IL-8 levels in pulp tissue, GCF, and dentin fluid samples routinely obtained during the treatment of healthy and symptomatic teeth diagnosed with irreversible pulpitis and investigate whether there is a correlation between them. A total of 70 patients aged 18-64 years with healthy (Group 1) and symptomatic irreversible pulpitis (Group 2) diagnosed at Kırıkkale University, Faculty of Dentistry, Department of Endodontics who will undergo routine root canal treatment will be included in the study, with a minimum of 35 participants for each group. Before starting treatment, DOS samples will be taken from healthy, symptomatic, irreversible pulpitis-diagnosed teeth and teeth contralateral to these teeth. A dentin fluid sample will be taken by holding the membrane on the dentin surface, and the pulp tissue will be removed and transferred to Eppendorf tubes. The treatment process will be completed by applying routine root canal procedures to the teeth. The samples' Aquaporin -4, -5, -9, and IL-8 levels will be analyzed by specific enzyme-linked immunosorbent assay (ELISA).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-20; most recent amendment 2025-11-27.
Trial Details
NCT Number NCT06938191
Lead Sponsor Kırıkkale University
Conditions Pulpitis, Pulpitis - Irreversible, Pulp Inflammation, Healthy Pulp, Biomarkers
Enrollment 70 participants
Start Date 2025-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-09-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-01